Literature DB >> 19097682

Performance of five phalangeal QUS parameters in the evaluation of gonadal-status, age and vertebral fracture risk compared with DXA.

Carlina V Albanese1, Chiara Cepollaro, Francesca de Terlizzi, Maria Luisa Brandi, Roberto Passariello.   

Abstract

The aim of this cross-sectional study was to study the value of five different quantified ultrasound (QUS) parameters-amplitude-dependent speed of sound (AD-SoS), Ultrasound Bone Profile Index (UBPI), fast-wave amplitude (FWA), bone transmission time (BTT) and signal dynamic (SDY)-measured at the phalanges of the hand in discriminating women with vertebral fracture and their relationship with some determinants of bone mass, in particular age and gonadal status compared with lumbar spine and hip dual-energy x-ray absorptiometry (DXA). We included 791 women aged 35-84 y, divided into pre-menopause, early menopause and late postmenopause groups on the basis of gonadal status and years since menopause (YSM). The presence of vertebral fracture was evaluated radiographically. All QUS parameters were very sensitive to changes in early postmenopause, with a doubled decrease in early postmenopausal with respect to late postmenopause. In particular AD-SoS and BTT decreases were markedly high in the early postmenopause group. In the late menopause group, similar decreases were observed for AD-SoS, UBPI and hip bone mineral density (BMD). In the multiple logistic model, DXA and QUS significantly discriminate women with and without fractures (p < 0.0001); odds ratio (OR) was higher at lumbar spine BMD (OR 4.01), FWA (OR 3.88), AD-SoS (OR 3.81) and total hip BMD (OR 3.77). Even adjusting the logistic model for age, height, weight, lumbar spine and total hip BMD, all QUS parameters remained significantly predictive of vertebral fracture. AD-SoS showed the best performances both in terms of OR and ROC analysis. QUS parameters show a different behavior in evaluating the effect on bone mass of the time since menopause; AD-SoS and BTT showed a high sensitivity to first changes in bone tissue after menopause. After correction for potential confounders, AD-SoS showed the same ability of lumbar spine BMD in discriminating women with or without vertebral fractures and in the prediction of fracture risk.

Entities:  

Mesh:

Year:  2008        PMID: 19097682     DOI: 10.1016/j.ultrasmedbio.2008.09.027

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  5 in total

1.  Quantitative ultrasound of the phalanges and DXA of the lumbar spine and proximal femur in evaluating the risk of osteoporotic vertebral fracture in postmenopausal women.

Authors:  C V Albanese; F De Terlizzi; R Passariello
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Brazilian pediatric reference data for quantitative ultrasound of phalanges according to gender, age, height and weight.

Authors:  Ezequiel Moreira Gonçalves; Roberto Regis Ribeiro; Wellington Roberto Gomes de Carvalho; Anderson Marques de Moraes; Everton Paulo Roman; Keila Donassolo Santos; Pedro Augusto Rodrigues Medaets; Nélio Neves Veiga-Junior; Adrielle Caroline Lace de Moraes Coelho; Tathyane Krahenbühl; Leticia Esposito Sewaybricker; Antonio de Azevedo Barros-Filho; Andre Moreno Morcillo; Gil Guerra-Júnior
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

3.  The Relation Between Calcaneus Stiffness Index as a Measure of Bone Density and Body Mass Index in an Egyptian Cohort.

Authors:  Khalid Ali; Salma Ms El Said; Nermien N Adly; Samia A Abdul-Rahman
Journal:  J Multidiscip Healthc       Date:  2019-12-31

4.  The Prevalence of Osteopenia and Osteoporosis Among Malaysian Type 2 Diabetic Patients Using Quantitative Ultrasound Densitometer.

Authors:  Shaymaa Abdalwahed Abdulameer; Mohanad Naji Sahib; Syed Azhar Syed Sulaiman
Journal:  Open Rheumatol J       Date:  2018-04-25

Review 5.  A review of menopause nomenclature.

Authors:  Ananthan Ambikairajah; Erin Walsh; Nicolas Cherbuin
Journal:  Reprod Health       Date:  2022-01-31       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.